On behalf of the International AIDS Society (IAS), Medscape, and our editors, we are pleased to introduce *eJIAS: eJournal of the International AIDS Society*, a new peer-reviewed journal dedicated to the science and practice of HIV/AIDS medicine in the developing world. And, on the occasion of the largest international gathering of HIV/AIDS scientists and healthcare and public health workers in 2 years, we are privileged to present the official online abstracts of the XV International AIDS Conference (Bangkok, Thailand; July 11--16, 2004) in this inaugural issue of *eJIAS*.

*eJIAS*<http://www.eJIAS.org> is an online, primary-source, peer-reviewed medical journal created to foster publication by researchers from developing countries and to enhance the accessibility and exchange of essential HIV/AIDS knowledge among frontline scientists, healthcare providers, and public health professionals working in diverse, but commonly resource-limited, settings. Copublished by IAS and Medscape, *eJIAS*is the first and only HIV/AIDS journal specifically for the publication of original, peer-reviewed articles that are highly relevant to the study, prevention, and treatment of HIV/AIDS in the developing world.

In keeping with the theme of the XV International AIDS Conference, \"Access for All,\" *eJIAS*seeks to encourage and facilitate publication by scientists and clinicians working in developing countries, and to thereby improve the dissemination of high-quality medical evidence from research conducted in a diversity of geographic, cultural, socioeconomic, and clinical settings. The 2-fold objective of these efforts is to enhance the quality and exchange of vital frontline HIV/AIDS data and knowledge, and to enable scientists and healthcare personnel to remain informed about research, analysis, and opinion relevant to the delivery of HIV/AIDS prevention, treatment, and care in developing countries and on a global scale.

*eJIAS*is available free of charge wherever there is a Web connection. To increase the accessibility and useful adoption of the journal, the contents of *eJIAS*are published in parallel, and indexed for MEDLINE, in *Medscape General Medicine*<http://www.MedGenMed.com>, Medscape\'s veteran, MEDLINE-indexed general-medicine journal. Through this unique collaborative approach and the combined membership, publishing, and program experience of IAS and Medscape, the research contributions and frontline perspectives published in *eJIAS*will reach more than 2 million healthcare professionals in 249 countries.

We are grateful to the Bristol-Myers Squibb Foundation for making the creation and launch of *eJIAS*possible through a founding grant from their Secure the Future program.

With this announcement, we dedicate *eJIAS*to our colleagues who are striving to change the course of AIDS around the world. It is our sincere hope that *eJIAS*will serve, creatively and consistently, to advance their best efforts and elevate the quality of research, information sharing, and education that must attend expanding global HIV/AIDS care initiatives.
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